XULANE (Mylan Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the XULANE drug offered from Mylan Pharmaceuticals Inc.. This Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Pharmaceuticals Inc.
NON-PROPRIETARY NAME: norelgestromin and ethinyl estradiol
SUBSTANCE NAME: NORELGESTROMIN; ETHINYL ESTRADIOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA]
ROUTE: TRANSDERMAL
DOSAGE FORM: PATCH
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-04-16
END MARKETING DATE: 0000-00-00


XULANE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionXULANE from Mylan Pharmaceuticals Inc.
LABELER NAME: Mylan Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 150; 35(ug/d; ug/d)
START MARKETING DATE: 2014-04-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0378-3340_d7a91bd6-f521-4093-8211-05c7a446c3c6
PRODUCT NDC: 0378-3340
APPLICATION NUMBER: ANDA200910

Other NORELGESTROMIN; ETHINYL ESTRADIOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Janssen Pharmaceutical, Inc.Ortho Evra
Mylan Pharmaceuticals Inc.XULANE